Cargando…

Immunogenicity and Effectiveness of Primary and Booster Vaccine Combination Strategies during Periods of SARS-CoV-2 Delta and Omicron Variants

In this study involving a cohort of employees of the National Airline company in Lebanon, we assessed humoral immunity levels and the effectiveness of two COVID-19 vaccines, Gam-COVID-Vac versus BNT162b2, after two doses and after a homologous and heterologous BNT162b2 booster, in addition to the im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moghnieh, Rima, El Hajj, Claude, Abdallah, Dania, Jbeily, Nayla, Bizri, Abdul Rahman, Sayegh, Mohamed H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607825/ https://www.ncbi.nlm.nih.gov/pubmed/36298460 http://dx.doi.org/10.3390/vaccines10101596

Ejemplares similares

Response to letter to the editor: Immunophenotyping of SARS-CoV-2 and vaccine design
por: Moghnieh, Rima, et al.
Publicado: (2022)

Immunogenicity and reactogenicity of BNT162b2 booster in BBIBP-CorV-vaccinated individuals compared with homologous BNT162b2 vaccination: Results of a pilot prospective cohort study from Lebanon
por: Moghnieh, Rima, et al.
Publicado: (2021)

COVID-19: Second Wave or Multiple Peaks, Natural Herd Immunity or Vaccine – We Should be Prepared
por: Moghnieh, Rima, et al.
Publicado: (2020)

Omicron Booster in Ancestral Strain Vaccinated Mice Augments Protective Immunities Against Both Delta and Omicron Variants
por: Jia, Liqiu, et al.
Publicado: (2022)

Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland
por: Norddahl, Gudmundur L., et al.
Publicado: (2022)

Immunity against Delta and Omicron variants elicited by homologous inactivated vaccine booster in kidney transplant recipients
por: Zhang, Lei, et al.
Publicado: (2023)

A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern
por: Schultz, Bárbara M., et al.
Publicado: (2022)

Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England
por: Kirsebom, Freja Cordelia Møller, et al.
Publicado: (2022)

Omicron variant and booster COVID-19 vaccines
por: Burki, Talha Khan
Publicado: (2022)

COVID vaccine booster doses for omicron variants
por: Burki, Talha
Publicado: (2022)

Reproduction Number of the Omicron Variant Triples That of the Delta Variant
por: Du, Zhanwei, et al.
Publicado: (2022)

Omicron variant: a booster depending on infection histories
por: Wang, Jiayu, et al.
Publicado: (2023)

Serial Intervals and Incubation Periods of SARS-CoV-2 Omicron and Delta Variants, Singapore
por: Zeng, Kangwei, et al.
Publicado: (2023)

Will New Variants Emerge after Delta and Omicron?
por: Yang, Zhen, et al.
Publicado: (2022)

Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants
por: Banerjee, Arinjay, et al.
Publicado: (2022)

Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants
por: Belik, Milja, et al.
Publicado: (2022)

Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
por: Chavda, Vivek P., et al.
Publicado: (2022)

A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
por: Lee, I-Jung, et al.
Publicado: (2022)

COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods
por: Mayr, Florian B., et al.
Publicado: (2022)

Patients Hospitalized for COVID-19 in the Periods of Delta and Omicron Variant Dominance in Greece: Determinants of Severity and Mortality
por: Karageorgou, Vagia, et al.
Publicado: (2023)

Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant
por: Zhao, Xin, et al.
Publicado: (2022)

Effectiveness of mRNA booster doses against the omicron variant
por: Zedan, Hadeel T, et al.
Publicado: (2022)

The 2018 Lebanese Society of Infectious Diseases and Clinical Microbiology Guidelines for the use of antimicrobial therapy in complicated intra-abdominal infections in the era of antimicrobial resistance
por: Haddad, Nicholas, et al.
Publicado: (2019)

Will the COVID-19 pandemic end with the Delta and Omicron variants?
por: Wang, Chaoqi, et al.
Publicado: (2022)

Cost-Effectiveness Analysis of COVID-19 Vaccine Booster Dose in the Thai Setting during the Period of Omicron Variant Predominance
por: Sirison, Kanchanok, et al.
Publicado: (2023)

Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron’s outbreak
por: Ren, Zhenxiao, et al.
Publicado: (2022)

Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods
por: Shoji, Kensuke, et al.
Publicado: (2023)

Inferring the differences in incubation-period and generation-interval distributions of the Delta and Omicron variants of SARS-CoV-2
por: Park, Sang Woo, et al.
Publicado: (2023)

DETECÇÃO DE ANTICORPOS NEUTRALIZANTES CONTRA AS VARIANTES DELTA, GAMA E OMICRON APÓS IMUNIZAÇÃO POR CORONAVAC E BOOSTER COM PFIZER
por: da Silva, Almir Ribeiro, et al.
Publicado: (2022)

Third booster vaccination and stopping the Omicron, a new variant of concern
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Third booster vaccination and stopping the Omicron, a new variant of concern
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Could Beta variant containing COVID-19 booster vaccines tackle Omicron variants?
por: Jin, Pengfei, et al.
Publicado: (2023)

LB750. Safety and Immunogenicity of a Bivalent Omicron-Containing Booster Vaccine against COVID-19
por: Chalkias, Spyros, et al.
Publicado: (2022)

GenomeBits insight into omicron and delta variants of coronavirus pathogen
por: Canessa, Enrique, et al.
Publicado: (2022)

Analysis of Factors Influencing the Clinical Severity of Omicron and Delta Variants
por: Zhao, Shanlu, et al.
Publicado: (2023)

Severity predictors of COVID-19 in SARS-CoV-2 variant, delta and omicron period; single center study
por: Ogawa, Fumihiro, et al.
Publicado: (2022)

COVID-19 disease severity in persons infected with the Omicron variant compared with the Delta variant in Qatar
por: Butt, Adeel A, et al.
Publicado: (2022)

Omicron adopts a different strategy from Delta and other variants to adapt to host
por: Du, Xiaohong, et al.
Publicado: (2022)

Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial
por: Kaabi, Nawal Al, et al.
Publicado: (2023)

Estimating the incubation period of SARS-CoV-2 Omicron BA.1 variant in comparison with that during the Delta variant dominance in South Korea
por: Liu, Yanwen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4f5aosspdsacg4uj6afuoc1clv